“…[1] Furthermore, the increasing interest in pharmaceutical compounds that may interfere on the in vivo oxidant status has led to studies for putative effects of allopurinol upon organ reperfusion injuries or upon disorders where endogenous antioxidant mechanisms are compromised, such as coronary heart disease, [2,3] diabetes, [4] and cirrhosis. [5] In this context, a variety of methods based on titrimetry, [6] spectrophotometry, [7][8][9] fluorimetry, [10] electrochemistry, [11][12][13][14] electrochemiluminescence, [15] and phosphorescence [16] are available for determination of allopurinol in pharmaceutical formulations. Methods for multi-analyte determination (including allopurinol) based on capillary electrophoresis [17] or HPLC with UV detection [18] have also been described.…”